Tower Research Capital LLC (Trc) Nutri Band Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.29 Billion
Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Nutri Band Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 825 shares of NTRB stock, worth $4,933. This represents 0.0% of its overall portfolio holdings.

Number of Shares

825

Previous 1,572 47.52%

Holding current value

$4,933

Previous $7,000 28.57%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$4.07 - $9.39 $3,040 - $7,014	-747 Reduced 47.52%	825 $5,000
Q4 2024 Feb 13, 2025	BUY	$3.85 - $8.39 $6,052 - $13,189	1,572 New	1,572 $7,000
Q2 2024 Aug 13, 2024	BUY	$3.35 - $6.16 $3,611 - $6,640	1,078 Added 35.22%	4,139 $22,000
Q1 2024 May 15, 2024	SELL	$2.3 - $4.52 $39 - $76	-17 Reduced 0.55%	3,061 $13,000
Q4 2023 Feb 13, 2024	BUY	$1.93 - $3.02 $1,800 - $2,817	933 Added 43.5%	3,078 $7,000
Q3 2023 Nov 14, 2023	SELL	$2.38 - $4.63 $4,914 - $9,560	-2,065 Reduced 49.05%	2,145 $5,000
Q2 2023 Aug 14, 2023	BUY	$2.04 - $3.86 $2,223 - $4,207	1,090 Added 34.94%	4,210 $12,000
Q1 2023 May 09, 2023	BUY	$2.9 - $4.96 $4,352 - $7,444	1,501 Added 92.71%	3,120 $10,000
Q4 2022 Feb 10, 2023	BUY	$3.53 - $4.5 $5,065 - $6,457	1,435 Added 779.89%	1,619 $6,000
Q3 2022 Nov 10, 2022	SELL	$3.49 - $7.83 $9,876 - $22,158	-2,830 Reduced 93.9%	184 $0
Q2 2022 Aug 15, 2022	BUY	$2.81 - $5.69 $2,970 - $6,014	1,057 Added 54.01%	3,014 $12,000
Q1 2022 May 12, 2022	BUY	$3.3 - $9.43 $2,484 - $7,100	753 Added 62.54%	1,957 $8,000
Q4 2021 Feb 14, 2022	BUY	$3.14 - $10.08 $3,780 - $12,136	1,204 New	1,204 $12,000

Others Institutions Holding NTRB

# of Institutions

Shares Held

341K

Call Options Held

Put Options Held

View Full List

About NutriBand Inc.

Ticker NTRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,803,260
Market Cap $46.7M
Description
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...

More about NTRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Nutri Band Inc. Transaction History